Product Information
NAPROXEN SOD ER 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $9.5851 per EA under NDC 00480095258. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Aug 27, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the naproxen sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480095258
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA075416FDA Approved
8/27/2002
TE Code
AB
On Market Since
11/1/2022
Pharmacological Classes
Price Statistics
The NADAC for NAPROXEN SOD ER 500 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5851 per EA |
|---|---|
| All-time high | $9.5930 (Aug 12, 2026) |
| All-time low | $8.0200 (Aug 21, 2024) |
| 52-week high | $9.5930 |
| 52-week low | $8.1286 |
| Median price | $8.9303 |
| Average price | $8.8831 |
| Largest weekly change | +15.1% (Nov 20, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naproxen sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naproxen sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NAPROXEN SOD ER 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN SOD ER 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $9.5851 per EA (NDC 00480095258), effective Sep 30, 2026.
How has the price of NAPROXEN SOD ER 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for NAPROXEN SOD ER 500 MG TABLET has risen 2.6%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for NAPROXEN SOD ER 500 MG TABLET?
Since Apr 17, 2024, the NADAC for NAPROXEN SOD ER 500 MG TABLET has ranged from a low of $8.0200 (Aug 21, 2024) to a high of $9.5930 (Aug 12, 2026), with a median of $8.9303 per EA.
Are there cheaper alternatives to NAPROXEN SOD ER 500 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of NAPROXEN SOD ER 500 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NAPROXEN SOD ER 500 MG TABLET?
NAPROXEN SOD ER 500 MG TABLET (NDC 00480095258) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.